Hosp, a Southern California Rising Star Honoree, Profiled in Super Lawyers Magazine
18 June 2020
Partner Phillip Hosp was profiled in the Super Lawyers magazine article, “Bronze Star Recipient Phillip Hosp’s path to the law went through Iraq.”
In the profile Hosp discussed his military career, which began as a member of the ROTC at Boston University. He served two tours of duty in Iraq and was awarded the Bronze Star for helping to save the lives of his platoon after a close encounter with an IED in a parked car in Iraq.
He decided to attend law school after returning from Iraq in 2006. Hosp told Super Lawyers magazine that he still finds a deep connection between the military and the law. “In a combat zone, you are presented with situations you can’t look up in the field manual,” he said. “You have to find the most logical and commonsense answer, which is also what you do as a litigator. The military focuses on how your decision-making is affected by other people’s decision-making, on tactic and finding the best grounds to fight on. Those are things I think about every day.”
Hosp is a member of Foley’s Business Litigation & Disputer Resolution Practice and works in the Los Angeles office.
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”